Efficacy and safety of 1% atropine on retardation of moderate myopia progression in chinese school children

A randomized, controlled study evaluating atropine and placebo in 660 Chinese children. Patients received drops q1month for 24 months, then q2month for 12 months, followed by no drops for 12 months.